SinoBioData Academic Portal
WM
Verified CAS / Academic Author2 Decoded Studies

Prof. WANG Miao

Shaanxi Academy of Traditional Chinese Medicine

Research Publications & English Decoded Briefs

Showing 2 publications
Stem Cell Research & Therapy2024DOI: 10.1186/s13287-024-03821-1

Transplantation of human endometrial perivascular stem cells with hydroxy saffron yellow A promotes uterine repair in rats

Background Intrauterine adhesions (IUAs) jeopardise uterine function in women, which is a great challenge in the clinic. Previous studies have shown that endometrial perivascular cells (En-PSCs) can improve the healing of scarred uteri and that hydroxysafflor yellow A (HSYA) promotes angiogenesis. The purpose of this study was to observe whether the combination of En-PSCs with HSYA could improve the blood supply and fertility in the rat uterus after full-thickness injury. Methods En-PSCs were sorted by flow cytometry, and the effect of HSYA on the proliferation and angiogenesis of the En-PSCs was detected using CCK-8 and tube formation assays. Based on a previously reported rat IUA model, the rat uteri were sham-operated, spontaneously regenerated, or treated with collagen-loaded PBS, collagen-loaded HSYA, collagen-loaded En-PSCs, or collagen-loaded En-PSCs with HSYA, and then collected at both 30 and 90 days postsurgery. HE staining and Masson staining were used to evaluate uterine structure and collagen fibre deposition, and immunohistochemical staining for α-SMA and vWF was used to evaluate myometrial regeneration and neovascularization in each group. A fertility assay was performed to detect the recovery of pregnancy function in each group. RNA-seq was performed to determine the potential mechanism underlying En-PSCs/HSYA treatment. Immunofluorescence, tube formation assays, and Western blot were used to validate the molecular mechanism involved. Results The transplantation of Collagen/En-PSCs/HSYA markedly promoted uterine repair in rats with full-thickness injury by reducing fibrosis, increasing endometrial thickness, regenerating myometrium, promoting angiogenesis, and facilitated live births. RNA sequencing results suggested that En-PSCs/HSYA activated the NRG1/ErbB4 signaling pathway. In vitro tube formation experiments revealed that the addition of an ErbB inhibitor diminished the tube formation ability of cocultured En-PSCs and HUVECs. Western blot results further showed that elevated levels of NRG1 and ErbB4 proteins were detected in the Collagen/En-PSCs/HSYA group compared to the Collagen/En-PSCs group. These collective results suggested that the beneficial effects of the transplantation of Collagen/En-PSCs/HSYA might be attributed to the modulation of the NRG1/ErbB4 signaling pathway. Conclusions The combination of En-PSCs/HSYA facilitated morphological and functional repair in rats with full-thickness uterine injury and may promote endometrial angiogenesis by regulating the NRG1/ErbB4 signaling pathway.

Chinese Traditional and Herbal Drugs2026DOI: 10.7501/j.issn.0253-2670.2026.16.20261609

Preparation and Anti-Migraine Pharmacodynamic Evaluation of Puerarin-Loaded Chitosan-Modified β-Cyclodextrin Nasal Supramolecular Gel

Puerarin, a principal isoflavone from Pueraria lobata, exhibits anti-migraine activity but suffers from poor oral bioavailability and limited blood-brain barrier penetration. This study reports a puerarin-loaded chitosan-modified β-cyclodextrin supramolecular gel (Pur@CS-β-CD Gel) for intranasal delivery. Formulation optimization employed single-factor experiments and Box-Behnken design-response surface methodology (BBD-RSM). The optimal formulation comprised CS-β-CD and sodium carboxymethylcellulose at a mass ratio of 1:9, total polymer concentration 2.6%, and puerarin 40 mg. The resulting gel displayed a three-dimensional porous architecture, pH 6.5, favorable stability, and a biphasic in vitro release profile: 82.75% cumulative release within 4 h followed by sustained release. No nasal mucosal irritation was observed. In a chronic migraine rat model induced by nitroglycerin, Pur@CS-β-CD Gel significantly ameliorated behavioral deficits, reduced brain levels of calcitonin gene-related peptide (CGRP) and interleukin-1β (IL-1β), and elevated 5-hydroxytryptamine (5-HT). These pharmacodynamic outcomes are consistent with interruption of trigeminovascular CGRP release, modulation of serotonergic neurotransmission, and attenuation of IL-1β-mediated nociceptive sensitization. The study acknowledges limitations: the animal model only partially recapitulates clinical migraine heterogeneity; long-term safety and immunogenicity of repeated dosing remain unassessed; and direct quantification of brain puerarin concentration was not performed, leaving brain-targeting efficiency unproven. Nonetheless, the optimized gel offers a feasible, non-invasive nasal delivery platform with preliminary anti-migraine efficacy, warranting further pharmacokinetic and mechanistic validation.